Find premium medical devices reports

DocStore » Research Reports » Medical Devices

Per Page: 15 25 50

«1...

Synovics Pharmaceuticals, Inc. (SYVC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Synovics Pharmaceuticals, Inc. (Synovics) is a US based Pharmaceutical company. It is engaged in developing, manufacturing and distribution of generic over the counter (OTC) pharmaceutical products and generic prescription drugs. Its OTC product categories include: analgesics, cough and cold, antihistamines, asthma relief and laxatives. Maneesh Pharmaceuticals limited India based drug firm has 51 percent stake in the company. Synovics has two subsidiaries Kirk Pharmaceuticals, LLC and ANDAPharm, LLC. Kirk is engaged in marketing and distribution of private-label OTC versions of analgesics, cold and allergy medicines. ANDAPharm is engaged in product research and RX manufacturing activities. The company is headquartered at Fort Lauderdale in Florida, United States.
Symbollon Pharmaceuticals, Inc. (SYMBA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Symbollon Pharmaceuticals, Inc. (Symbollon) is a pharmaceutical company that is focused on the development and commercialization of proprietary drugs based on its molecular iodine technology. Its products find their applications in two distinct areas; women's healthcare and antimicrobial applications. Its iodine technology accomplishes this by controlling the ratio of molecular iodine. Symbollon's products include IodoZyme, a powdered product that uses the enzyme horseradish peroxidase to enzymatically form molecular iodine upon dissolution in water, and IoGen is the first solid oral dosage form that delivers molecular iodine upon dissolution in gastric fluid. Its product IoGen solves the long-standing problem of providing an oral dosage form for molecular iodine that is stable, tasteless and well tolerated. The company is headquartered in Massachusetts, the US.
Titan Pharmaceuticals, Inc. (TTNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Titan Pharmaceuticals, Inc. (Titan Pharmaceuticals) is a pharmaceutical and health care service provider, based in the US. The company develops therapeutics for the treatment of central nervous system disorders. Its products include Probuphine used for the treatment of opioid addiction, Iloperidone used for the treatment of schizophrenia and related psychotic disorders, Spheramine used for the treatment of advanced Parkinson’s disease. The company is in alliance with Novarties Pharma, AG, has licensed the rights to commercialize Fanapt in the US. and Canada, and commenced marketing the product in the US. It has presented phase 3 Probuphine data at society for neuroscience annual meeting. Titan Pharmaceuticals is headquartered in South San Francisco, California, the US.
Nanobac Pharmaceuticals, Inc. (NNBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Nanobac Pharmaceuticals, Inc (Nanobac) is the US based bio-lifescience company. It is focused on the research and treatment of degenerative diseases caused due to nanobacterial infections. The company commercializes diagnostics and prescription nanobiotic medications employed for the treatment of coronary heart disease, atherosclerosis and other degenerative diseases. Nanobac’s research is chiefly conducted on the pathogenic role of nanobacteria in soft tissue calcification, mostly in coronary artery heart disease, prostatitis and vascular disease. The company also holds focused drug discovery and development of new and existing compounds that inhibit, destroy and neutralize Calcifying Nanoparticles. In Vitro Diagnostic (IVD) kits and reagents are manufactured and also marketed by the company. IVD kits are used to detect calcifying nanoparticles. The company’s IVD product line comprise of antibodies, assays, and reagents that recognize CNPs. Nanobac operates through it's subsidiary called Finnish Subsidiary, Nanobac OY in developed markets of European Union. It is headquartered in Tampa
PHC, Inc. (PHC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

PHC, Inc., (Pioneer Behavioral Health) is a healthcare company that is engaged in offering behavioral healthcare services to its customers. The company offers its services by entering into contracts with national insurance companies, government agencies, gaming and transportation companies. PHC customer base includes patients with alcohol and drug dependency related disorders, psychiatric disorders and corporate employees in transportation and gaming industries. The company operates under two business operating units namely hospital and clinical services, and integrated delivery services. It also operates in five states in the US and its programs include substance abuse treatment facilities in Virginia and Utah, outpatient and inpatient psychiatric facilities in Nevada and Michigan. Its Wellplace division provides telephonic and internet based referral services like critical incident and EAP services. PHC is headquartered at Peabody in Massachusetts, the US.
Oncogenex Pharmaceuticals, Inc. (OGXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Oncogenex Pharmaceuticals, Inc. (OncoGenex) is a pharmaceutical and health care service provider, based in the US. The company develops and commercializes innovative cancer therapeutics. Its products include OGX-011, OGX-427 and OGX-225 as its lead products which targets on the mechanisms of treatment resistance in cancer patients and develops to block the specific proteins production. The company’s product custirsen is an experimental drug that blocks the production of clusterin, a cell-survival protein that is over-produced in several malignancies and in response to many cancer treatments. Its other products include OGX-225, an inhibitor of insulin growth factor binding proteins two and five and CSP-9222 under pre-clinical development. OncoGenex is headquartered in Bothell, Washington, the US.
Conmed Healthcare Management, Inc. (CONM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Conmed Healthcare Management, Inc. (Conmed Healthcare) is a Pharmaceuticals and Healthcare service provider company, based the US. The center provides healthcare services in therapeutic areas and primary care. The healthcare services that include general healthcare services, acute care services, dialysis services, surgical services, laboratory services, diagnostic services, Mouth and Dental Disorders, hospital services, mental health services, physical and occupational therapy and dental services. Its services are performed through multiple-year, fixed-cost contracts. Conmed Healthcare also provides administrative general healthcare and ancillary services. Conmed Healthcare acquired the healthcare company Panhandle Correctional Care, Inc. The healthcare operates through its services in Arizona, Kansas, Oklahoma, Maryland, Oregon, Virginia and Washington. Conmed Healthcare is headquartered in Hanover, Maryland, the US.
Repros Therapeutics Inc. (RPRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Repros Therapeutics, Inc., (Repros) is a pharmaceutical and health care service provider, based in the US. The company develops molecule drugs for the treatment of male and female reproductive disorders. Its products include proellex, a selective blocker of the progesterone receptor; and Androxal, a single isomer of clomiphene citrate and an orally active small molecule compound. The company develops Proellex for three indications such as chronic treatment of symptoms associated with uterine fibroids, anemia associated with uterine fibroids, and chronic treatment of symptoms associated with endometriosis. It also develops androxal to restore normal pituitary response in men resulting in normalization of testosterone and luteinizing hormone levels. Repros is headquartered in Woodlands, Texas, the US.
Repligen Corporation (RGEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Repligen Corporation (Repligen) is a biopharmaceutical company indulged in discovery, development and commercialization of novel therapeutics in the areas of neurology and gastroenterology. The company also has a bio-processing business to develop and market products which are then used in production of biopharmaceuticals. The commercialized portfolio of the company includes a line of bio-processing products based on Protein A as well as a product line of pre-packed chromatography columns used for the purification of biopharmaceuticals and vaccines under the trade name Opus. The pipeline product portfolio of the Repligen includes RG 1068 or secretin (under the trade name SecreFlo) which is currently in Phase III clinical trial stage for the MRI imaging of pancreas and Phase-II clinical trial stage for pancreatic cancer; RG2833 (Histone Deacetylase Inhibitors) which is pre-clinical stage being developed for the treatment of Friedreich’s Ataxia and memory discorders; and RG3039 (DcpS Inhibitors) which is inPhase I clinical trial stage for the treatment of spinal muscular atrophy. The drug candidate RG1068 has received a orphan drug and fast track drug designation from the US Food and Drug Administration (FDA). The company has a network of direct sales force and distribution partners for the marketing of its bio-processing products. Repligen is headquartered at Waltham in Massachusetts, the US.
Poniard Pharmaceuticals, Inc. (PARD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Poniard Pharmaceuticals, Inc. (Poniard) is a publicly held bio-pharmaceutical company engaged in developing and commercializing cancer therapy products. The company focused on developing picoplatin product, which is a new generation platinum based cancer therapy. Picoplatin is designed to overcome platinum resistance in the treatment of solid tumors. In addition, the company conducts clinical trials of intravenous picoplatin, including a Phase 3 trial in small cell lung cancer and two Phase 2 trials in metastatic colorectal and hormone-refractory prostate cancers. Poniard conducts Phase 1 clinical trial of oral picoplatin in patients with solid tumors. The company is headquartered in South San Francisco, the US.
Regeneron Pharmaceuticals, Inc. (REGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Regeneron Pharmaceuticals, Inc. (Regeneron) is a biopharmaceutical company that discovers, develops, manufactures pharmaceutical products for the treatment of serious ailments. The company's product portfolio covers varied therapeutic areas including inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders. Currently it has two marketed products, Eylea (aflibercept) and Arcalyst (rilonacept) and 13 products in various stages of clinical development. Arcalyst is indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Auto-inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS) in adults and children older than 12 years and Eylea also called VEGF Trap, is indicated for the treatment of neovascular age-related macular degeneration (wet AMD). Regeneron is headquartered in Tarrytown, NewYork, the US.
RegeneRx Biopharmaceuticals, Inc. (RGRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

RegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company, based in the US. It provides research facilities for vaccine discovery for treatment of diseases such as immune system disorders. The company conducts research and develops novel pharmaceuticals that protect and repair tissue and organ damage caused by disease, trauma or other pathology. The company’s products include RGN-352 injectable, RGN-259 Eye Drops, RGN-137 topical, RGN-457 inhalation, cystic fibrosis, bronchiectasis, diabetic vitrectomy, multiple sclerosis, and others. RegeneRx Biopharmaceuticals has developed thymosin beta 4 for the treatment of injured tissue and non-healing wounds to enable more rapid repair and tissue regeneration. The company is doing research on the development of Tß4, Tß4 peptide fragments for assisting cosmeceutical applications. RegeneRx Biopharmaceuticals is headquartered in Bethesda, Maryland, the US.
Teikoku Seiyaku Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Teikoku Seiyaku Co., Ltd. (Teikoku Seiyaku) is a pharmaceutical company, based in Japan. The company develops, manufactures and distributes medicated and medically related supplies. It offers poultices which include Lidoderm, medicated patches and plaster, and anti-inflammatory plasters. Teikoku Seiyaku produces prescription drugs such as, Dovonex ointment, Hap Star ID, Glycerin Enema, Steronema, Bari-Enema, Magtect U, and Zikilion syrups. The company markets its products in Europe and the US. It operates through its subsidiaries in the UK, the US and China. The company has additional offices in Tokushima, Tokyo, and Osaka. It was established in 1848. Teikoku Seiyaku is headquartered in Higashikagawa, Kagawa, Japan.
Techne Corporation (TECH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

TECHNE Corporation (TECHNE) is a holding company based in the US. The company is in the development, production and sale of biotechnology products and hematology products including calibrators and controls. It operates thorough its two business divisions, namely, The Hematology Division and The Biotechnology Division. The Hematology Division of the company is in the development and manufacturing of hematology controls, used in hospitals and clinical laboratories to check the accuracy of blood analysis instruments. The Biotechnology Division of the company is in the development and manufacturing of biotechnological products including purified proteins (cytokines), assays, enzymes, diagnostic kits and antibodies that are sold primarily to the research market and assay kits which are sold to the research and clinical diagnostic markets. The company operates in the China, Europe and the US. It has a subsidiary in England, R&D systems Europe Ltd., which distributes TECHNE’s products in Europe. TECHNE is headquartered in Minneapolis, Minnesota, the US.
Bio3 Research S.r.l - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Bio3 Research s.r.l (Bio3) is a biopharmaceutical company, based in Italy. It develops new proprietary compounds in the cardiovascular field. The company focuses in the field of tissue regeneration such as, wound healing, cartilage repair, bone matrix regeneration, burns, and bed sores, among others. It has strategic alliance with Syngen Inc. and Protelix Inc. for the development SIRNA HMGB1 specific and Mimic Abs anti-HMGB1 in cardiovascular field. The company collaborates with biopharmaceutical companies, academies, and individual scientists to identify innovations to patent and develop them for commercial fruition in the pharmaceutical marketplace. It operates through its subsidiary in California. Bio3 is headquartered in Milan, Italy.

Per Page: 15 25 50

«1...

Medical Devices

Find premium medical devices research reports. Purchase and download high quality report analysis, industry reports, medical device technology reports, company research reports, and much more

DocStore Search:

DocStore » Research Reports » Medical Devices

Synovics Pharmaceuticals, Inc. (SYVC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Symbollon Pharmaceuticals, Inc. (SYMBA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Titan Pharmaceuticals, Inc. (TTNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nanobac Pharmaceuticals, Inc. (NNBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PHC, Inc. (PHC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oncogenex Pharmaceuticals, Inc. (OGXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Conmed Healthcare Management, Inc. (CONM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Repros Therapeutics Inc. (RPRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Repligen Corporation (RGEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Poniard Pharmaceuticals, Inc. (PARD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Regeneron Pharmaceuticals, Inc. (REGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Teikoku Seiyaku Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Techne Corporation (TECH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bio3 Research S.r.l - Pharmaceuticals & Healthcare - Deals and Alliances Profile